APO RESEARCH · REPORT
Venous Stents
This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen.
Product & engineering
Understand the product.
This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen.
Selected research
Market Outlook & Growth Opportunities
Global Venous Stents Market Outlook and Growth Opportunities 2026
Market perspective
This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen.
In the US market, the major manufacturers are Boston Scientific, Boston Scientific, Medtronic, Veniti, Cook Medical, Optimed Med and C. R. Bard.
This report provides an overview of the global Venous Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Venous Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Venous Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Venous Stents market size, projected growth trends, production technologies, key applications, and end-use industries.
Venous Stents Segment by Company
Boston Scientific
Medtronic
Veniti
Cook Medical
Optimed Med
C. R. Bard
Venous Stents Segment by Type
10 mm Stent
12 mm Stent
14 mm Stent
16 mm Stent
Venous Stents Segment by Application
Leg
Chest
Abdomen
Others
Venous Stents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Venous Stents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Venous Stents market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Venous Stents significant trends, drivers, influence factors in global and regions.
6. To analyze Venous Stents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Venous Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Venous Stents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Venous Stents industry.
Chapter 3: Detailed analysis of Venous Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Venous Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Venous Stents in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 10 mm Stent
- 12 mm Stent
- 14 mm Stent
- 16 mm Stent
Applications
- Leg
- Chest
- Abdomen
- Others
Companies covered
- Boston Scientific
- Medtronic
- Veniti
- Cook Medical
- Optimed Med
- C. R. Bard
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Venous Stents Sales Value (2021-2032)
- 1.2.2 Global Venous Stents Sales Volume (2021-2032)
- 1.2.3 Global Venous Stents Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Venous Stents Market Dynamics
- 2.1 Venous Stents Industry Trends
- 2.2 Venous Stents Industry Drivers
- 2.3 Venous Stents Industry Opportunities and Challenges
- 2.4 Venous Stents Industry Restraints
3 Venous Stents Market by Company
- 3.1 Global Venous Stents Company Revenue Ranking in 2025
- 3.2 Global Venous Stents Revenue by Company (2021-2026)
- 3.3 Global Venous Stents Sales Volume by Company (2021-2026)
- 3.4 Global Venous Stents Average Price by Company (2021-2026)
- 3.5 Global Venous Stents Company Ranking (2024-2026)
- 3.6 Global Venous Stents Company Manufacturing Base and Headquarters
- 3.7 Global Venous Stents Company Product Type and Application
- 3.8 Global Venous Stents Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Venous Stents Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Venous Stents Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Venous Stents Market by Type
- 4.1 Venous Stents Type Introduction
- 4.1.1 10 mm Stent
- 4.1.2 12 mm Stent
- 4.1.3 14 mm Stent
- 4.1.4 16 mm Stent
- 4.2 Global Venous Stents Sales Volume by Type
- 4.2.1 Global Venous Stents Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Venous Stents Sales Volume by Type (2021-2032)
- 4.2.3 Global Venous Stents Sales Volume Share by Type (2021-2032)
- 4.3 Global Venous Stents Sales Value by Type
- 4.3.1 Global Venous Stents Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Venous Stents Sales Value by Type (2021-2032)
- 4.3.3 Global Venous Stents Sales Value Share by Type (2021-2032)
5 Venous Stents Market by Application
- 5.1 Venous Stents Application Introduction
- 5.1.1 Leg
- 5.1.2 Chest
- 5.1.3 Abdomen
- 5.1.4 Others
- 5.2 Global Venous Stents Sales Volume by Application
- 5.2.1 Global Venous Stents Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Venous Stents Sales Volume by Application (2021-2032)
- 5.2.3 Global Venous Stents Sales Volume Share by Application (2021-2032)
- 5.3 Global Venous Stents Sales Value by Application
- 5.3.1 Global Venous Stents Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Venous Stents Sales Value by Application (2021-2032)
- 5.3.3 Global Venous Stents Sales Value Share by Application (2021-2032)
6 Venous Stents Regional Sales and Value Analysis
- 6.1 Global Venous Stents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Venous Stents Sales by Region (2021-2032)
- 6.2.1 Global Venous Stents Sales by Region: 2021-2026
- 6.2.2 Global Venous Stents Sales by Region (2027-2032)
- 6.3 Global Venous Stents Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Venous Stents Sales Value by Region (2021-2032)
- 6.4.1 Global Venous Stents Sales Value by Region: 2021-2026
- 6.4.2 Global Venous Stents Sales Value by Region (2027-2032)
- 6.5 Global Venous Stents Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Venous Stents Sales Value (2021-2032)
- 6.6.2 North America Venous Stents Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Venous Stents Sales Value (2021-2032)
- 6.7.2 Europe Venous Stents Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Venous Stents Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Venous Stents Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Venous Stents Sales Value (2021-2032)
- 6.9.2 South America Venous Stents Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Venous Stents Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Venous Stents Sales Value Share by Country, 2025 VS 2032
7 Venous Stents Country-level Sales and Value Analysis
- 7.1 Global Venous Stents Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Venous Stents Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Venous Stents Sales by Country (2021-2032)
- 7.3.1 Global Venous Stents Sales by Country (2021-2026)
- 7.3.2 Global Venous Stents Sales by Country (2027-2032)
- 7.4 Global Venous Stents Sales Value by Country (2021-2032)
- 7.4.1 Global Venous Stents Sales Value by Country (2021-2026)
- 7.4.2 Global Venous Stents Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Venous Stents Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Venous Stents Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Venous Stents Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Venous Stents Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Venous Stents Sales Value Growth Rate (2021-2032)
- 7.9.2 France Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Venous Stents Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Venous Stents Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Venous Stents Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Venous Stents Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Venous Stents Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Venous Stents Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Venous Stents Sales Value Growth Rate (2021-2032)
- 7.16.2 China Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Venous Stents Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Venous Stents Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Venous Stents Sales Value Growth Rate (2021-2032)
- 7.19.2 India Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Venous Stents Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Venous Stents Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Venous Stents Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Venous Stents Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Venous Stents Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Venous Stents Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Venous Stents Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Venous Stents Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Venous Stents Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Venous Stents Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Venous Stents Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Venous Stents Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Venous Stents Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Venous Stents Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Venous Stents Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Venous Stents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Boston Scientific
- 8.1.1 Boston Scientific Company Information
- 8.1.2 Boston Scientific Business Overview
- 8.1.3 Boston Scientific Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Boston Scientific Venous Stents Product Portfolio
- 8.1.5 Boston Scientific Recent Developments
- 8.2 Medtronic
- 8.2.1 Medtronic Company Information
- 8.2.2 Medtronic Business Overview
- 8.2.3 Medtronic Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Medtronic Venous Stents Product Portfolio
- 8.2.5 Medtronic Recent Developments
- 8.3 Veniti
- 8.3.1 Veniti Company Information
- 8.3.2 Veniti Business Overview
- 8.3.3 Veniti Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Veniti Venous Stents Product Portfolio
- 8.3.5 Veniti Recent Developments
- 8.4 Cook Medical
- 8.4.1 Cook Medical Company Information
- 8.4.2 Cook Medical Business Overview
- 8.4.3 Cook Medical Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Cook Medical Venous Stents Product Portfolio
- 8.4.5 Cook Medical Recent Developments
- 8.5 Optimed Med
- 8.5.1 Optimed Med Company Information
- 8.5.2 Optimed Med Business Overview
- 8.5.3 Optimed Med Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Optimed Med Venous Stents Product Portfolio
- 8.5.5 Optimed Med Recent Developments
- 8.6 C. R. Bard
- 8.6.1 C. R. Bard Company Information
- 8.6.2 C. R. Bard Business Overview
- 8.6.3 C. R. Bard Venous Stents Sales, Value and Gross Margin (2021-2026)
- 8.6.4 C. R. Bard Venous Stents Product Portfolio
- 8.6.5 C. R. Bard Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Venous Stents Value Chain Analysis
- 9.1.1 Venous Stents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Venous Stents Sales Mode & Process
- 9.2 Venous Stents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Venous Stents Distributors
- 9.2.3 Venous Stents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst